Your browser doesn't support javascript.
loading
Targeting of PI3K/AKT signaling and DNA damage response in acute myeloid leukemia: a novel therapeutic strategy to boost chemotherapy response and overcome resistance.
Estruch, Montserrat; Vittori, Camilla; Montesinos, Teresa Muñoz; Reckzeh, Kristian; Theilgaard-Mönch, Kim.
Afiliación
  • Estruch M; The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.
  • Vittori C; Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.
  • Montesinos TM; Authors contributed equally.
  • Reckzeh K; The Finsen Laboratory, Rigshospitalet/National University Hospital, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.
  • Theilgaard-Mönch K; Biotech Research and Innovation Centre, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen DK-2200, Denmark.
Cancer Drug Resist ; 4(4): 984-995, 2021.
Article en En | MEDLINE | ID: mdl-35582388
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Cancer Drug Resist Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Cancer Drug Resist Año: 2021 Tipo del documento: Article País de afiliación: Dinamarca